Showing 48,901 - 48,920 results of 226,405 for search '(( a ((((larger decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a latest decrease ))', query time: 2.03s Refine Results
  1. 48901

    Heterologous expression of <i>trsA</i> in <i>C. elegans</i> causes severe morphological alterations. by Jennifer Emser (22120206)

    Published 2025
    “…The nematodes expressing <i><i>trsA</i></i> show a lower survival rate from day 10 on, with a strong decrease after day 13. …”
  2. 48902

    Image_1_Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.pdf by Qian Zhou (125859)

    Published 2022
    “…According to the current meta-analysis, which demonstrated that there was a significant decrease in waist circumference (SMD = –0.36; 95% CI: –0.59, –0.14; P = 0.002; I<sup>2</sup> = 88%), hemoglobin A1c (–0.48; –0.69, –0.27; P ≤ 0.001; I<sup>2</sup> = 94%), total cholesterol (–0.15; –0.3, –0.01; P = 0.003; I<sup>2</sup> = 94%), low density lipoprotein cholesterol (–0.42; –0.57, –0.27; P ≤ 0.001; I<sup>2</sup> = 92%), high density lipoprotein cholesterol (0.16; –0.31, –0.02; P = 0.03; I<sup>2</sup> = 81%) following resveratrol administration.…”
  3. 48903

    Alterations in the vitamin D endocrine system during pregnancy: A longitudinal study of 855 healthy Norwegian women by Miriam K. Gustafsson (5089163)

    Published 2018
    “…Estimate of change between trimesters was (95% CI): 25(OH)D -1.8 (-2.8 to -0.7) nmol/L, DBP 0.62 (0.57 to 0.66) μmol/L, calculated free 25(OH)D -1.7 (-2.0 to -1.4) pmol/L, PTH 0.81 (0.72 to 0.90) pmol/L, 1,25(OH)<sub>2</sub>D (sub-analysis) 31.4 (CI 24.7 to 38.2) pmol/L. A decrease in 1,25(OH)<sub>2</sub>D occurred in 45% of those with vitamin D deficiency, and they also exhibited lower levels than women with adequate vitamin D status. …”
  4. 48904

    Image_13_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”
  5. 48905

    Image_7_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”
  6. 48906

    A priori prediction of the probability of survival in vehicle crashes using anthropomorphic test devices and human body models by Sebastian Büchner (6838013)

    Published 2019
    “…Therefore, we present and validate a protocol for the aggregation of injury risks of body regions to a probability of survival (PoS).…”
  7. 48907

    Image_2_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”
  8. 48908

    Image_6_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”
  9. 48909

    Image_5_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”
  10. 48910

    Image_10_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”
  11. 48911

    Image_3_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”
  12. 48912

    Image_8_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”
  13. 48913

    Image_1_Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.pdf by Qian Zhou (125859)

    Published 2022
    “…According to the current meta-analysis, which demonstrated that there was a significant decrease in waist circumference (SMD = –0.36; 95% CI: –0.59, –0.14; P = 0.002; I<sup>2</sup> = 88%), hemoglobin A1c (–0.48; –0.69, –0.27; P ≤ 0.001; I<sup>2</sup> = 94%), total cholesterol (–0.15; –0.3, –0.01; P = 0.003; I<sup>2</sup> = 94%), low density lipoprotein cholesterol (–0.42; –0.57, –0.27; P ≤ 0.001; I<sup>2</sup> = 92%), high density lipoprotein cholesterol (0.16; –0.31, –0.02; P = 0.03; I<sup>2</sup> = 81%) following resveratrol administration.…”
  14. 48914

    DataSheet3_Investigation of anti-diabetic effect of a novel coenzyme Q10 derivative.ZIP by Xiaojun Tan (548013)

    Published 2023
    “…Moreover, L-50 could increase fasting insulin levels (FINS) in HFD/STZ mice, leading to a decrease in fasting blood glucose (FBG) and hepatic glycogen. …”
  15. 48915

    Image_4_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”
  16. 48916

    Image_9_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”
  17. 48917

    A General Approach to Controlling the Surface Composition of Poly(ethylene oxide)-Based Block Copolymers for Antifouling Coatings by Michael D. Dimitriou (471912)

    Published 2011
    “…Increasing the incorporation of <i>f</i>AGE led to an increased amount of perfluorocarbons on the surface and a decrease in the concentration of PS. At a <i>f</i>AGE incorporation of 8 mol %, PS was not detected at the surface, as measured by NEXAFS spectroscopy. …”
  18. 48918

    DataSheet2_Investigation of anti-diabetic effect of a novel coenzyme Q10 derivative.ZIP by Xiaojun Tan (548013)

    Published 2023
    “…Moreover, L-50 could increase fasting insulin levels (FINS) in HFD/STZ mice, leading to a decrease in fasting blood glucose (FBG) and hepatic glycogen. …”
  19. 48919

    MdFDIA: A Mass Defect Based Four-Plex Data-Independent Acquisition Strategy for Proteome Quantification by Yi Di (4445635)

    Published 2017
    “…The subtle mass differences between the four labeled forms in MS<sup>2</sup> scans can be resolved on an Orbitrap Fusion Lumos instrument to facilitate quantification without abundance information encoded in MS<sup>2</sup> spectra. Additionally, a systematic investigation was carried out and revealed that MdFDIA enabled a significant decrease of the adverse impact on the accuracy of the quantitative assays arising from the chromatographic isotope effect, especially the deuterium effect, which typically occurs in a DDA experiment. …”
  20. 48920

    Image_15_Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.TIF by Haiming Wang (13998)

    Published 2021
    “…<p>Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. …”